Sellas Life Sciences Group Inc SLS shares are trading lower by 35.7% to $0.58 Thursday
afternoon. The stock is trading lower after the company announced pricing of a $9 million public offering.

Untangling the Web

The issuance of 12 million shares of common stock alongside accompanying warrants
aims to raise $9 million before expenses.

Priced at $0.75 per share and warrant, these securities will grant the option to
purchase an equal number of shares at the same price within five years.

A.G.P./Alliance Global Partners acts as the exclusive placement
agent for this offering, set to conclude around January 8, pending standard closing conditions.

Also Valuable: December Jobs Report Preview

Data from Benzinga Pro reveals that SLS has reached a 52-week high of $4.13 and a
low of $0.58.